At the time of the acquisition of The Works, they were forecasting an EBITDA form The works of 3.9M plus an extra 1.5M in synergies for FY18. Looks like the core business has been going backwards.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game